封面
市场调查报告书
商品编码
1684442

自动注射器市场,按类型、按疾病适应症、按最终用户、按国家和地区 - 2025 年至 2032 年的行业分析、市场规模、市场份额和预测

Autoinjectors Market, By Type, By Disease Indication, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日期: | 出版商: AnalystView Market Insights | 英文 284 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告重点

2024 年自动注射器市场规模价值为 11.0232 亿美元,2025 年至 2032 年期间的复合年增长率为 13.90%。

自动注射器市场-市场动态

过敏反应、慢性疾病的日益普及以及药物传递的进步预计将推动市场需求

全球自动注射器市场预计将显着成长,这主要受多种因素的推动,包括慢性和紧急医疗状况发病率的上升、药物输送系统的进步。糖尿病、类风湿性关节炎和多发性硬化症等慢性疾病需要定期注射药物。自动注射器为患者提供了一种高效且使用者友好的自我用药方式,提高了治疗方案的依从性。严重的过敏反应通常由食物、昆虫叮咬或药物引起,需要立即使用肾上腺素治疗。像 EpiPen 这样的自动注射器被设计用于在过敏发作期间快速且准确地註射肾上腺素。人们对过敏反应及其可能危及生命的后果的认识不断提高,推动了对肾上腺素自动注射器的需求。

此外,自动注射器设计的技术进步使得这些设备更加用户友好、安全和有效。具有连接功能的智慧型自动注射器可以追踪注射时间表,提高依从性。自动注射器消除了对经过训练的药物管理人员的需求。此外,FDA 和 EMA 等监管机构加快了对创新型自动注射器的审批,促进其进入市场。此外,许多国家优惠的报销政策使患者更容易获得这些设备,从而进一步提高了采用率。

自动注射器市场-关键见解

根据我们的研究分析师的分析,预测期内(2025-2032 年),全球市场预计年复合成长率约为 13.90%

根据类型细分,预计一次性产品由于其易于使用和供应,将在 2024 年占据最大的市场份额。

根据疾病适应症细分,糖尿病领域已成为 2024 年领先的疾病适应症领域,因为糖尿病患者护理对胰岛素注射的需求不断增加。

根据最终用户细分,由于自我管理药物的趋势日益上升,家庭护理设定细分市场将成为 2024 年领先的最终用户细分市场。

按地区划分,由于糖尿病盛行率高,北美将成为 2024 年的主要收入来源。类风湿性关节炎等

自动注射器市场-細項分析:

全球自动注射器市场根据类型、疾病指征、最终用户和地区进行细分。

根据类型,市场分为两类:一次性和可重复使用。一次性产品占据市场主导地位。便利性和提高治疗方案依从性等好处正在促进这一细分市场的需求。

根据疾病指征,市场分为五类:糖尿病、类风湿性关节炎、过敏反应、硬化症和其他。由于全球糖尿病盛行率高,预计糖尿病领域将占据最大份额,而精准剂量的可用性正在推动市场成长。

根据最终用户,市场分为三类:家庭护理环境、医院和门诊手术中心。家庭护理设定部分在最终用户部分占有最大的份额。先进的医疗保健的采用和自我药疗的更大便利预计将增加该领域的需求。

自动注射器市场-地理洞察

在全球范围内,自动注射器市场广泛分布于北美、拉丁美洲、欧洲、亚太地区以及中东和非洲地区。北美在全球自动注射器市场占据主导地位。糖尿病、过敏性休克和类风湿性关节炎等慢性病的高发性,加上先进的医疗保健基础设施和自我管理意识的增强,推动了市场的成长。由于慢性病发病率不断上升,预计亚太地区将出现自动注射器市场的最高成长率。医疗保健意识的不断提高、中国、印度和日本等国家的经济成长以及政府为提高医疗保健的可及性和可负担性而采取的倡议是推动市场发展的关键因素。

自动注射器市场-竞争格局:

自动注射器市场具有显着的成长特征,这得益于技术创新、主要参与者之间的策略合作以及人们对自我用药的偏好日益增长。市场参与者提供广泛的自我注射和输液系统产品组合,例如,Ypsomed 专注于地理扩展和以患者为中心的产品。该公司推出了 YpsoMate 5.5,这是一个先进的自动注射器平台,专为容量范围为 1.5 毫升至 5.5 毫升的液体药物而设计。生物相似药和生物製剂的批准增加扩大了可用于自动注射器输送的药物范围,促进了市场成长。

最新动态:

2024年3月,Ypsomed开始向MTD集团出售胰岛素笔针和血糖监测解决方案,以开发先进的智慧帮浦。

2023 年 10 月,Altaviz 推出了用于药物输送和生物製剂的 AltaVISC 自动注射器平台。

目录

第 1 章:自动注射器市场概述

  • 研究范围
  • 市场估计年限

第 2 章:执行摘要

  • 市场片段
    • 自动注射器市场片段(按类型)
    • 自动注射器市场片段(按疾病适应症)
    • 自动注射器市场片段(按最终用户)
    • 自动注射器市场片段(按国家/地区)
    • 自动注射器市场片段(按地区)
  • 竞争洞察

第 3 章:自动注射器主要市场趋势

  • 自动注射器市场驱动因素
    • 市场驱动因素的影响分析
  • 自动注射器市场限制
    • 市场限制的影响分析
  • 自动注射器市场机会
  • 自动注射器市场未来趋势

第 4 章:自动注射器产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景规划
  • 规范架构分析

第五章:自动注射器市场:地缘政治紧张局势升级的影响

  • 新冠肺炎疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第 6 章:自动注射器市场格局

  • 2024 年自动注射器市占率分析
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第 7 章:自动注射器市场 - 按类型

  • 概述
    • 按类型分類的细分市场占有率分析
    • 一次性的
    • 可重复使用的

第 8 章:自动注射器市场 - 按疾病适应症

  • 概述
    • 按疾病适应症分類的细分份额分析
    • 糖尿病
    • 类风湿关节炎
    • 过敏反应
    • 硬化
    • 其他的

第 9 章:自动注射器市场 - 按最终用户

  • 概述
    • 按最终用户细分的份额分析
    • 家庭护理设置
    • 医院
    • 门诊手术中心

第 10 章:自动注射器市场 - 按地区划分

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美自动注射器主要製造商
    • 北美市场规模及预测(按国家/地区)
    • 北美市场规模和预测(按类型)
    • 北美市场规模及预测(依疾病类型划分)
    • 北美市场规模和预测(按最终用户)
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲自动注射器主要製造商
    • 欧洲市场规模及预测(按国家)
    • 欧洲市场规模与预测(按类型)
    • 欧洲市场规模及预测(依疾病类型划分)
    • 欧洲市场规模和预测(按最终用户)
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区自动注射器主要製造商
    • 亚太地区市场规模及预测(依国家/地区划分)
    • 亚太地区市场规模及预测(按类型)
    • 亚太地区市场规模及预测(依疾病类型划分)
    • 亚太地区市场规模及预测(依最终用户)
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲 (LATAM)
    • 概述
    • 拉丁美洲自动注射器主要製造商
    • 拉丁美洲市场规模及预测(按国家/地区)
    • 拉丁美洲市场规模及预测(按类型)
    • 拉丁美洲市场规模及预测(依疾病类型划分)
    • 拉丁美洲市场规模及预测(按最终用户)
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲 (MEA)
    • 概述
    • 中东和非洲自动注射器主要製造商
    • MEA 市场规模及预测(依国家/地区划分)
    • MEA 市场规模和预测(按类型)
    • MEA 市场规模及预测(依疾病类型划分)
    • MEA 市场规模和预测(按最终用户)
    • 沙乌地阿拉伯
    • 阿联酋
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其他地区

第 11 章:主要供应商分析-自动注射器产业

  • 竞争仪錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • SHL Medical AG
    • Ypsomed AG
    • Becton, Dickinson and Company
    • Eli Lilly and Company
    • Amgen Inc.
    • Altaviz
    • Teva Pharmaceutical Industries Ltd.
    • Novartis AG
    • Pfizer Inc.
    • Antares Pharma, Inc.
    • Mylan NV
    • Gerresheimer AG
    • Owen Mumford Ltd.
    • Jabil Healthcare
    • Medeca Pharma AB
    • Credence MedSystems, Inc.
    • Others

第 12 章:360 度分析师视角

第 13 章:附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4790

REPORT HIGHLIGHT

Autoinjectors Market size was valued at USD 1,102.32 Million in 2024, expanding at a CAGR of 13.90% from 2025 to 2032.

Autoinjectors are a kind of medical device designed to deliver a specific dose of medication, typically through an intramuscular or subcutaneous injection. They are often used for emergency or self-administration of drugs where quick and precise delivery is critical. These devices are preloaded with medication and feature a spring-loaded mechanism, making them easy to use, even for individuals without medical training.

Autoinjectors Market- Market Dynamics

Growing prevalence of anaphylaxis, chronic disorders and advancement in drug delivery are expected to propel market demand

The global autoinjectors market is expected to witness a significant growth, driven by a confluence of factors, including rising incidences of chronic and emergency medical conditions, advancements in drug delivery systems. Chronic diseases such as diabetes, rheumatoid arthritis, and multiple sclerosis require regular administration of injectable drugs. Autoinjectors provide an efficient and user-friendly way for patients to self-administer medication, improving adherence to treatment regimens. Severe allergic reactions, often triggered by food, insect stings, or medications, require immediate treatment with epinephrine. Autoinjectors like EpiPen are designed for rapid and accurate delivery of epinephrine during anaphylactic episodes. The increasing awareness of anaphylaxis and its potentially life-threatening consequences is driving the demand for epinephrine autoinjectors.

Further, technological advancements in autoinjector design have made these devices more user-friendly, safe, and effective. Smart autoinjectors with connectivity features allow tracking of injection schedules, enhancing compliance. Autoinjectors eliminate the need for trained personnel for drug administration. Moreover, regulatory bodies like the FDA and EMA have expedited approvals for innovative autoinjectors, facilitating their market entry. Additionally, favorable reimbursement policies in many countries make these devices more accessible to patients, further boosting adoption rates.

Autoinjectors Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 13.90% over the forecast period (2025-2032)

Based on Type segmentation, the disposable segment was predicted to show maximum market share in the year 2024, due to their ease of use & availability.

Based on Disease Indication segmentation, the diabetes segment was the leading Disease Indication segment in 2024, due to increasing need for insulin injections in diabetic patient care.

Based on End User segmentation, the homecare settings segment was the leading End User segment in 2024, due to the rising trend of self-administered medications.

On the basis of region, North America was the leading revenue generator in 2024, owing to high prevalence of diabetes. rheumatoid arthritis, etc.

Autoinjectors Market- Segmentation Analysis:

The Global Autoinjectors Market is segmented on the basis of Type, Disease Indication, End User, and Region.

The market is divided into two categories based on Type: disposable and reusable. The disposable segment dominates the market. Benefits such as convenience and improved compliance with treatment regimen are contributing to segment demand.

The market is divided into five categories based on the Disease Indication: diabetes, rheumatoid arthritis, anaphylaxis, sclerosis, and others. The diabetes segment is expected to hold the largest share due to the high prevalence of diabetes worldwide and availability of precise dosing is boosting market growth.

The market is divided into three categories based on End User: homecare settings, hospitals, and ambulatory surgical centers. The homecare settings segment holds the largest share in the End User segment. The adoption of advanced healthcare and greater convenience in self-medications are expected to increase segment demand.

Autoinjectors Market- Geographical Insights

Across the world, the Autoinjectors market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America dominates in the global Autoinjectors market. The high prevalence of chronic conditions such as diabetes, anaphylaxis, and rheumatoid arthritis, coupled with advanced healthcare infrastructure and increased awareness about self-administration, propels market growth. The Asia Pacific region is anticipated to witness the highest growth rate in the autoinjectors market, driven by the increasing prevalence of chronic diseases. Rising healthcare awareness, economic growth in countries like China, India, and Japan, and government initiatives to enhance healthcare access and affordability are key factors propelling market development.

Autoinjectors Market- Competitive Landscape:

The autoinjectors market is characterized by significant growth, driven by technological innovations, strategic collaborations among key players, and an increasing preference for self-administration of medications. Market players offer an extensive portfolio of self-injection and infusion systems, for example, Ypsomed focuses on geographic expansion and patient-centric products. The company introduced the YpsoMate 5.5, an advanced autoinjector platform designed for liquid medications in the volume range of 1.5 ml to 5.5 ml. The increase in approvals for biosimilars and biologics expands the range of medications available for autoinjector delivery, contributing to market growth.

Recent Developments:

In March 2024, Ypsomed started selling insulin pen needle and blood sugar monitoring solutions to MTD Group to develop advanced smart pumps.

In October 2023, Altaviz launched the AltaVISC auto-injector platform for drug delivery & biologics.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL AUTOINJECTORS MARKET KEY PLAYERS

  • SHL Medical AG
  • Ypsomed AG
  • Becton, Dickinson and Company
  • Eli Lilly and Company
  • Amgen Inc.
  • Altaviz
  • Teva Pharmaceutical Industries Ltd.
  • Novartis AG
  • Pfizer Inc.
  • Antares Pharma, Inc.
  • Mylan N.V.
  • Gerresheimer AG
  • Owen Mumford Ltd.
  • Jabil Healthcare
  • Medeca Pharma AB
  • Credence MedSystems, Inc.
  • Others

GLOBAL AUTOINJECTORS MARKET, BY TYPE- MARKET ANALYSIS, 2019-2032

  • Disposable
  • Reusable

GLOBAL AUTOINJECTORS MARKET, BY DISEASE INDICATION- MARKET ANALYSIS, 2019-2032

  • Diabetes
  • Rheumatoid arthritis
  • Anaphylaxis
  • Sclerosis
  • Others

GLOBAL AUTOINJECTORS MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Homecare settings
  • Hospitals
  • Ambulatory surgical centers

GLOBAL AUTOINJECTORS MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Autoinjectors Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Autoinjectors Market Snippet by Type
    • 2.1.2. Autoinjectors Market Snippet by Disease Indication
    • 2.1.3. Autoinjectors Market Snippet by End User
    • 2.1.4. Autoinjectors Market Snippet by Country
    • 2.1.5. Autoinjectors Market Snippet by Region
  • 2.2. Competitive Insights

3. Autoinjectors Key Market Trends

  • 3.1. Autoinjectors Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Autoinjectors Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Autoinjectors Market Opportunities
  • 3.4. Autoinjectors Market Future Trends

4. Autoinjectors Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Autoinjectors Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Autoinjectors Market Landscape

  • 6.1. Autoinjectors Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Autoinjectors Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
    • 7.1.2. Disposable
    • 7.1.3. Reusable

8. Autoinjectors Market - By Disease Indication

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Disease Indication, 2024 & 2032 (%)
    • 8.1.2. Diabetes
    • 8.1.3. Rheumatoid arthritis
    • 8.1.4. Anaphylaxis
    • 8.1.5. Sclerosis
    • 8.1.6. Others

9. Autoinjectors Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Homecare settings
    • 9.1.3. Hospitals
    • 9.1.4. Ambulatory surgical centers

10. Autoinjectors Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Autoinjectors Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Autoinjectors Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Autoinjectors Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Autoinjectors Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Autoinjectors Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Autoinjectors Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. SHL Medical AG
    • 11.2.2. Ypsomed AG
    • 11.2.3. Becton, Dickinson and Company
    • 11.2.4. Eli Lilly and Company
    • 11.2.5. Amgen Inc.
    • 11.2.6. Altaviz
    • 11.2.7. Teva Pharmaceutical Industries Ltd.
    • 11.2.8. Novartis AG
    • 11.2.9. Pfizer Inc.
    • 11.2.10. Antares Pharma, Inc.
    • 11.2.11. Mylan N.V.
    • 11.2.12. Gerresheimer AG
    • 11.2.13. Owen Mumford Ltd.
    • 11.2.14. Jabil Healthcare
    • 11.2.15. Medeca Pharma AB
    • 11.2.16. Credence MedSystems, Inc.
    • 11.2.17. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us